Research Article

Association between Multiple Sclerosis and FOXP3 Gene Promoter Region Mutations

Volume: 40 Number: 3 September 30, 2018
EN

Association between Multiple Sclerosis and FOXP3 Gene Promoter Region Mutations

Abstract

Regulatory T-Cells (Treg Cells), as one of the immune system components, have been highly effective in the autoimmune diseases prevention, particularly multiple sclerosis (MS). MS is a chronic inflammatory and autoimmune disease characterized by immune infiltration and inflammation in the central nervous system. Regulatory T (Treg) cells play an important role in the control of autoimmunity. Expression and action of the transcription factor FOXP3 controls the development and function of Treg cell. The aim of this study was to investigate the association between MS and FOXP3 gene promoter region polymorphisms rs2232365 (-924A/G) and rs3761548 (-3279A/C) in a Turkish population. In this case-control study we investigated these polymorphisms in 80 MS patients and 80 healthy controls using PCR-RFLP methods.

Results of our study showed that while there is significant correlation between MS and FOXP3 rs3761548 polymorphism (p=0.031), FOXP3 rs2232365 polymorphism, has not been found to be associated with the disease (p=0.31).  As FOXP3 gene is one of the most important genes in the regulation of the immune cells, it may be concluded that the expression of this gene is important in MS patients. As this SNP is located in the promoter region of the gene, it may affect the expression level of FOXP3 protein.

Keywords

References

  1. 1. Hafler DA, Slavik JM, Anderson DE, O’Connor KC, De Jager P, Baecher-Allan C. Multiple sclerosis. Immunol Rev, 2005; 204:208-231.
  2. 2. İdiman E. Multipl skleroz’un immünopatogenezi. Türkiye Klinikleri J Neur, 2004; 2:171-176.
  3. 3. Weissert R. The immune pathogenesis of Multiple sclerosis. Pharmacol, 2013; 8:857-866.
  4. 4. Piccirillo AC, Shevach ME. Naturally occuring CD4(+)CD25(+) immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol, 2004; 16(2):81-88.
  5. 5. Işık N, Yıldız-Manukyan N, Aydın-Cantürk İ, Candan F, Ünsal-Çakmak A, Saruhan-Direskeneli G. Multipl skleroza genetik yatkınlık: Foxp3 gen polimorfizmin rolü. Nöropsikiyatri Arşivi, 2014; 51:69-73.
  6. 6. Singer BD, King LS, D’Alessio FR. Regulatory T cells as immunotherapy. Front Immunol, 2014; 5:46.
  7. 7. Viglietta V, Baecher-Allan C, Weiner HI, Hafler DA. Loss of functional supression by CD4+CD25+ regulatory T cells from patients with Multiple sclerosis. J Exp Med, 2004; 199:971-979.
  8. 8. Yadav SK, Mindur JE, Ito K, Dhib-Jalbut S. Advances in the immunopathogenesis of Multiple sclerosis. Curr Opin Neurol, 2015; 28:206-219.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Authors

Aslihan Esra Bildirici
Türkiye

Seyda Akin
Türkiye

Ozlem Kayim Yildiz
Türkiye

Publication Date

September 30, 2018

Submission Date

April 27, 2018

Acceptance Date

July 4, 2018

Published in Issue

Year 1970 Volume: 40 Number: 3

AMA
1.Cekin N, Pinarbasi E, Bildirici AE, Akin S, Kayim Yildiz O. Association between Multiple Sclerosis and FOXP3 Gene Promoter Region Mutations. CMJ. 2018;40(3):226-232. doi:10.7197/223.vi.419261

Cited By